Search for Clinical Trial Results

Sponsored By

Congenital Amegakaryocytic Thrombocytopenia - 6 Studies Found

Status Study
Completed Study Name: Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease
Condition:
  • Congenital Amegakaryocytic Thrombocytopenia
  • Leukemia
  • Date: 2006-02-23
    Interventions:
    • Biological: anti-thymocyte globulin
    • Biolog
Completed Study Name: Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders
Condition:
  • Congenital Amegakaryocytic Thrombocytopenia
  • Diamond-blackfan An
    Date: 2006-03-09
    Interventions:
    • Biological: alemtuzumab
    • Drug: busulfan
Completed Study Name: Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission
Condition:
  • Congenital Amegakaryocytic Thrombocytopenia
  • Diamond-blackfan An
    Date: 2006-03-21
    Interventions:
    • Biological: anti-thymocyte globulin
    • Drug:

Active, not recruiting Study Name: Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remissi
    Date: 2012-02-06
    Interventions:
    • Drug: fludarabine phosphate Gi
Completed Study Name: Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells
Condition:
  • Sickle Cell Disease
  • Thalassemia
  • Anemia
  • Primary Immunodeficiency Syndromes
  • Congenital Bone Marrow Failure Syndromes
  • Drug: Hydroxyurea Hydroxyurea